Latino Semaglutide Study (LSS),
Role: Investigator,
Novo Nordisk Pharmaceuticals Inc.,
(07/2022 - 10/2024)
Status: Completed
Internal
The Weight Loss Journey of Center for Health Promotion Patients who have taken the Weight-Loss Medication Saxenda, a GLP-1 (Glucagon Like Peptide 1) Analogue,
Role: PI,
LLU Dept. of Preventive Medicine (SM),
(05/2021)
Status: Approved
Functional assessment of ashwagandha root extract during weight-loss,
Role: Investigator,
LLU Center for Health Research,
(06/2020 - 06/2021)
Status: Completed